现代各种组学和高通量筛选技术为人们带来了大量潜在的药物靶标。生物制药公司和研发机构为保证在药物靶标的开发中获得最大限度的投资回报,往往对药物靶标申请专利保护。尽管如此,药物靶标开发中仍然有许多专利问题尚未明确。本文采用定性与定量的研究方法,对药物靶标开发中涉及的问题进行分析,并提出我国应采取的药物靶标专利策略。 Various modern omics and high-throughput screening technologies have brought a large number of potential drug targets. Biopharmaceutical companies and R & D institutions often patent their drug targets to ensure maximum return on their investment in the development of drug targets. Nevertheless, there are still many patent issues in the development of drug targets that are not yet clear. This article uses qualitative and quantitative research methods to analyze the problems involved in the development of drug targets, and puts forward the drug target patent strategy that our country should take.